Davis Investment Partners, LLC
Source: SEC Form 13F · as of Mar 2026Davis Investment Partners, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $20.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$20.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 28,815 | $7.0M |
| ABBVAbbVie Inc. | 10,221 | $2.2M |
| AMGNAMGEN INC | 4,611 | $1.6M |
| MRKMerck & Co., Inc. | 13,151 | $1.6M |
| LLYELI LILLY & Co | 1,206 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,316 | $1.0M |
| NVSNovartis AG | 5,658 | $864K |
| BMYBRISTOL MYERS SQUIBB CO | 14,110 | $856K |
| BIIBBIOGEN INC. | 3,580 | $656K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 10,578 | $598K |
| NBIXNEUROCRINE BIOSCIENCES INC | 4,459 | $587K |
| GILDGILEAD SCIENCES, INC. | 4,121 | $574K |
| GMEDGlobus Medical Inc. | 6,567 | $566K |
| IQVIQVIA Holdings Inc. | 3,240 | $553K |
| ABTABBOTT LABORATORIES | 5,350 | $549K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.